Singapore Factory the World’s Largest Provider of Microfluidic Valves for Genetic Analysis
SINGAPORE, August 25, 2009 – Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex™ valves. The 250 million valves built into Fluidigm’s integrated fluidic circuits (IFCs) would be equivalent to the number of valves required [...]

Single Cell study holds the key to iPS Progress
Fluidigm Corporation today announced that the Center for iPS Cell Research and Application (CiRA; Director Dr. Shinya Yamanaka) of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), has introduced a BioMark™ System for Genetic Analysis. CiRA is using the unique microfluidic properties of the system’s integrated [...]

Single Cell study holds the key to Hematopoietic Stem Cell Progress
SOUTH SAN FRANCISCO, Calif. June 22, 2009 – Fluidigm Corporation today announced that Dr. Toshio Suda of Keio University’s 21st Century Center of Excellence (COE) Program, Graduate School of Medicine, has selected the BioMark™ System for Genetic Analysis to assist their research of mouse hematopoietic [...]

SOUTH SAN FRANCISCO, Calif. Feb. 18, 2009 – Fluidigm Corporation today announced that Stanford University has used the unique single-cell gene expression capabilities of the company’s integrated fluidic circuits (IFCs) to help identify the source of cancer stem cells’ resistance to radiation. Researchers applied the unique properties of the Fluidigm chip to isolate individual molecules [...]